Optimizing AAV Vectors for Gene Therapy of Muscle Diseases

Time: 11:30 am
day: Day Two

Details:

  •  Capsids, promoters and payloads
  • Activity in normal and diseased muscle
  • Enhanced Microdystrophins for DMD gene therapy

Speakers: